BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25568177)

  • 61. The influence of myeloid-derived suppressor cells on angiogenesis and tumor growth after cancer surgery.
    Wang J; Su X; Yang L; Qiao F; Fang Y; Yu L; Yang Q; Wang Y; Yin Y; Chen R; Hong Z
    Int J Cancer; 2016 Jun; 138(11):2688-99. PubMed ID: 26756887
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glycyrrhizic acid-mediated subdual of myeloid-derived suppressor cells induces antileishmanial immune responses in a susceptible host.
    Bandyopadhyay S; Bhattacharjee A; Banerjee S; Halder K; Das S; Paul Chowdhury B; Majumdar S
    Infect Immun; 2015 Dec; 83(12):4476-86. PubMed ID: 26351281
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor-induced CD14+HLA-DR (-/low) myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients.
    Wang Z; Zhang L; Wang H; Xiong S; Li Y; Tao Q; Xiao W; Qin H; Wang Y; Zhai Z
    Cancer Immunol Immunother; 2015 Mar; 64(3):389-99. PubMed ID: 25548095
    [TBL] [Abstract][Full Text] [Related]  

  • 64. miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.
    Liu Q; Zhang M; Jiang X; Zhang Z; Dai L; Min S; Wu X; He Q; Liu J; Zhang Y; Zhang Z; Yang R
    Int J Cancer; 2011 Dec; 129(11):2662-73. PubMed ID: 21213211
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice.
    Jeanbart L; Kourtis IC; van der Vlies AJ; Swartz MA; Hubbell JA
    Cancer Immunol Immunother; 2015 Aug; 64(8):1033-46. PubMed ID: 25982370
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Galectin-9 induced myeloid suppressor cells expand regulatory T cells in an IL-10-dependent manner in CVB3-induced acute myocarditis.
    Zhang Y; Jiang L; Zhang M; Lv K
    Int J Mol Sci; 2014 Feb; 15(3):3356-72. PubMed ID: 24573249
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab.
    Sade-Feldman M; Kanterman J; Klieger Y; Ish-Shalom E; Olga M; Saragovi A; Shtainberg H; Lotem M; Baniyash M
    Clin Cancer Res; 2016 Dec; 22(23):5661-5672. PubMed ID: 27178742
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
    Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
    Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.
    Younos I; Donkor M; Hoke T; Dafferner A; Samson H; Westphal S; Talmadge J
    Int Immunopharmacol; 2011 Jul; 11(7):816-26. PubMed ID: 21376153
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myeloid Suppressor Cells Accumulate and Regulate Blood Pressure in Hypertension.
    Shah KH; Shi P; Giani JF; Janjulia T; Bernstein EA; Li Y; Zhao T; Harrison DG; Bernstein KE; Shen XZ
    Circ Res; 2015 Oct; 117(10):858-69. PubMed ID: 26294657
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells.
    Liu G; Bi Y; Wang R; Yang H; Zhang Y; Wang X; Liu H; Lu Y; Zhang Z; Chen W; Chu Y; Yang R
    J Immunol; 2014 Apr; 192(7):3068-79. PubMed ID: 24567529
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis.
    Fujii W; Ashihara E; Hirai H; Nagahara H; Kajitani N; Fujioka K; Murakami K; Seno T; Yamamoto A; Ishino H; Kohno M; Maekawa T; Kawahito Y
    J Immunol; 2013 Aug; 191(3):1073-81. PubMed ID: 23804709
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activated Circulating Myeloid-Derived Suppressor Cells in Patients with Dilated Cardiomyopathy.
    Zhang WC; Wang YG; Wei WH; Xiong X; Liu KL; Wang DH; Hu XF; Peng YD; Wu JJ; Cheng LX
    Cell Physiol Biochem; 2016; 38(6):2438-51. PubMed ID: 27287545
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increased frequencies of CD11b(+) CD33(+) CD14(+) HLA-DR(low) myeloid-derived suppressor cells are an early event in melanoma patients.
    Rudolph BM; Loquai C; Gerwe A; Bacher N; Steinbrink K; Grabbe S; Tuettenberg A
    Exp Dermatol; 2014 Mar; 23(3):202-4. PubMed ID: 24495013
    [TBL] [Abstract][Full Text] [Related]  

  • 76. IFN-γ differentially regulates subsets of Gr-1(+)CD11b(+) myeloid cells in chronic inflammation.
    Zhan X; Fang Y; Hu S; Wu Y; Yang K; Liao C; Zhang Y; Huang X; Wu M
    Mol Immunol; 2015 Aug; 66(2):451-62. PubMed ID: 26021804
    [TBL] [Abstract][Full Text] [Related]  

  • 77. miR-150 inhibitor ameliorates adriamycin-induced focal segmental glomerulosclerosis.
    Qi H; Fu J; Luan J; Jiao C; Cui X; Cao X; Zhang Y; Wang Y; Kopp JB; Pi J; Zhou H
    Biochem Biophys Res Commun; 2020 Feb; 522(3):618-625. PubMed ID: 31787235
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Circulating CD14(+)HLA-DR(-/low) myeloid-derived suppressor cell is an indicator of poor prognosis in patients with ESCC.
    Huang H; Zhang G; Li G; Ma H; Zhang X
    Tumour Biol; 2015 Sep; 36(10):7987-96. PubMed ID: 25967454
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.
    Sawanobori Y; Ueha S; Kurachi M; Shimaoka T; Talmadge JE; Abe J; Shono Y; Kitabatake M; Kakimi K; Mukaida N; Matsushima K
    Blood; 2008 Jun; 111(12):5457-66. PubMed ID: 18375791
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia.
    Hou Y; Feng Q; Xu M; Li GS; Liu XN; Sheng Z; Zhou H; Ma J; Wei Y; Sun YX; Yu YY; Qiu JH; Shao LL; Liu XG; Hou M; Peng J
    Blood; 2016 Mar; 127(12):1587-97. PubMed ID: 26744458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.